12/16/2025
To continue on the available treatments for Parkinson’s Disease:
Vyalev Infusion Pump:
On Oct. 17, 2024 the U.S. Food and Drug Administration approved the medical device Vyalev, an infusion pump made by AbbVie that dispenses a formulation of foscarbidopa and foslevodopa continuously.
This infusion pump is similar to the insulin pumps known to treat people with diabetes.
The infusion pump is a consistent delivery of medications carbidopa and levodopa that are known to make a difference for Parkinson’s patients.
The pump enables fine-tuned dosing that’s hard to achieve with pills. It can provide an option for patients who aren’t interested in or, given their age or health status, makes deep-brain stimulation neurosurgery too high-risk.
By the time somebody’s five or 10 years into the disease course, there’s a high likelihood they would benefit from this treatment.
The benefits one person using the Vyalev infusion pump reports: improved sleep, improved mobility, and improved fine-motor skills.
Having the pump as a constant companion and took some getting used to, he said, and it weighs on him at times. But he no longer must set an iPhone reminder to take carbidopa-levodopa pills every four hours – reminders he sometimes missed, paying the price in more “off” time. The pump also keeps running at night, avoiding gaps during sleep.
Call on Hewes Health Consulting to help you investigate your treatment options, and arm you with the questions to ask your medical provider.
Let’s make sure you are well informed to that you can make the best informed decision for you.
Ready to start your journey?�
Transform your health with a personalized approach with HEWES HEALTH CONSULTING.
Book your FREE 15 minute consultation today and take the first step toward a better, healthier you!
📞 Call [410-271-4816] or Message [ [email protected] or Visit [heweshealthconsult.com] to learn more.